Ovoca Bio plc (ISE: OVXA)
Ireland
· Delayed Price · Currency is EUR
0.0055
-0.0090 (-62.07%)
Aug 6, 2024, 9:00 PM GMT
Ovoca Bio Statistics
Total Valuation
Ovoca Bio has a market cap or net worth of EUR 1.22 million. The enterprise value is -1.70 million.
Market Cap | 1.22M |
Enterprise Value | -1.70M |
Important Dates
The next estimated earnings date is Tuesday, December 24, 2024.
Earnings Date | Dec 24, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Ovoca Bio has 81.56 million shares outstanding. The number of shares has increased by 6.92% in one year.
Current Share Class | n/a |
Shares Outstanding | 81.56M |
Shares Change (YoY) | +6.92% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 36.18% |
Owned by Institutions (%) | n/a |
Float | 52.06M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.62 |
P/TBV Ratio | 0.55 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 0.48 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.59
Current Ratio | 3.59 |
Quick Ratio | 3.59 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 266.00 |
Financial Efficiency
Return on equity (ROE) is -108.96% and return on invested capital (ROIC) is 4.56%.
Return on Equity (ROE) | -108.96% |
Return on Assets (ROA) | 3.70% |
Return on Capital (ROIC) | 4.56% |
Revenue Per Employee | n/a |
Profits Per Employee | -714,600 |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.00% in the last 52 weeks. The beta is 0.91, so Ovoca Bio's price volatility has been similar to the market average.
Beta (5Y) | 0.91 |
52-Week Price Change | -45.00% |
50-Day Moving Average | 0.02 |
200-Day Moving Average | 0.01 |
Relative Strength Index (RSI) | 21.99 |
Average Volume (20 Days) | 475 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | 266,000 |
Pretax Income | -3.98M |
Net Income | -3.57M |
EBITDA | 595,000 |
EBIT | 266,000 |
Earnings Per Share (EPS) | -0.04 |
Balance Sheet
Cash & Cash Equivalents | 2.93M |
Total Debt | n/a |
Net Cash | 2.93M |
Net Cash Per Share | 0.04 |
Equity (Book Value) | 2.24M |
Book Value Per Share | 0.02 |
Working Capital | 2.24M |
Cash Flow
Operating Cash Flow | 404,000 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Ovoca Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.92% |
Shareholder Yield | -6.92% |
Earnings Yield | -273.28% |
FCF Yield | n/a |
Stock Splits
The last stock split was on January 18, 2010. It was a reverse split with a ratio of 0.2.
Last Split Date | Jan 18, 2010 |
Split Type | Reverse |
Split Ratio | 0.2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |